Aparito has been shortlisted in the Best Digital Health Solution category at the 2022 Prix Galien UK Awards for our clinical trial platform, Atom5™!

atom5

The Prix Galien is UK life sciences’ most prestigious award for innovation and Aparito appears amongst a field of digital health luminaries including Behold.ai, Big Health, Cera, Docobo Ltd, Feedback Medical Ltd, ieso Digital Health, Holmusk, Huma, syd™, Islacare, Spirit Health, Tympa Health Technologies Ltd, uMotif, and Wondr Medical.

To be shortlisted for the Prix Galien UK Awards is a thrilling milestone for the whole team and further recognition of our collective mission to bring clinical trials to patients, from ultra rare genetic diseases to others such as Long COVID which impact thousands.

Dr Elin Haf Davies, CEO of Aparito

According to the press release, The Prix Galien UK Awards launched in 1990 and have been awarded to 36 products since its inception. Winners are selected every two years by the Prix Galien UK Awards Committee, which is comprised of 14 experts in the field. The Committee comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.

The winner will be announced during the Prix Galien UK Awards ceremony which takes place May 12 2022 at London’s Natural History Museum.

Schedule a call

Schedule a call to learn more about Aparito and Atom5™